{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:51:13Z","timestamp":1791247873637,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-039626"],"award-info":[{"award-number":["INV-039626"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Serosurveillance for vaccine-preventable diseases (VPDs) can inform public health strategies by identifying gaps in immunization programs. However, venous blood sampling, though reliable and sensitive for serosurveillance, presents logistical challenges in resource-limited settings. Capillary microsampling using dried blood spots (DBS) offers a simpler, less invasive alternative that reduces cold-chain and personnel requirements. This study evaluated the performance and stability of DBS collected on filter paper and Mitra microsamplers compared with venous plasma. IgG antibody levels against diphtheria, tetanus, pertussis, measles, mumps, rubella, and varicella were quantified using a validated fluorescent bead-based multiplex immunoassay. At baseline, strong agreement was observed between DBS and plasma, with \u2265\u200993% of observations within the 95% limits of agreement. Sensitivity was high (\u2265\u200995.8%) for all pathogens except pertussis (72.2\u201377.8%). For DBS stored at \u2212\u00a020\u00a0\u00b0C with desiccants, agreement remained high at 90 days, with gradual declines observed beyond one year. At room temperature, IgG levels declined, with sensitivity\u2009\u2265\u200991.2% at 7 and 30 days but dropping below 90% by 90 days for several analytes. Beyond one year, IgG recovery was minimal, with sensitivity\u2009&lt;\u200950% for most pathogens. These findings support DBS utility for VPD serosurveillance, with stability up to 90 days at \u2212\u00a020\u00a0\u00b0C and 30 days at room temperature.<\/jats:p>","DOI":"10.1038\/s41598-026-61174-6","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:45:33Z","timestamp":1783356333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of capillary microsampling and venous blood for multi-pathogen serosurveillance"],"prefix":"10.1038","volume":"16","author":[{"given":"Rose","family":"Ombati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makobu","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Akech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Kutima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antipa K.","family":"Sigilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boniface","family":"Karia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Osoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Karani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdhalah","family":"Ziraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfrey","family":"Bigogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Munywoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Anthony G.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrose","family":"Agweyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Wangeci","family":"Kagucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5430-6011","authenticated-orcid":false,"given":"James","family":"Nyagwange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"61174_CR1","doi-asserted-by":"publisher","first-page":"e1655","DOI":"10.1016\/S2214-109X(22)00379-5","volume":"10","author":"MV Murhekar","year":"2022","unstructured":"Murhekar, M. V. et al. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018\u20132020. Lancet Global Health. 10, e1655\u2013e1664 (2022).","journal-title":"Lancet Global Health"},{"key":"61174_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.antiviral.2011.12.011","volume":"93","author":"IJM Snijdewind","year":"2012","unstructured":"Snijdewind, I. J. M. et al. Current and future applications of dried blood spots in viral disease management. Antiviral Res. 93, 309\u2013321 (2012).","journal-title":"Antiviral Res."},{"key":"61174_CR3","doi-asserted-by":"publisher","first-page":"e0248218","DOI":"10.1371\/journal.pone.0248218","volume":"16","author":"F Amini","year":"2021","unstructured":"Amini, F. et al. Reliability of dried blood spot (DBS) cards in antibody measurement: A systematic review. PLoS ONE. 16, e0248218 (2021).","journal-title":"PLoS ONE"},{"key":"61174_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4269\/ajtmh.13-0463","volume":"90","author":"PW Smit","year":"2014","unstructured":"Smit, P. W., Elliott, I., Peeling, R. W., Mabey, D. & Newton, P. N. An Overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am. Soc. Trop. Med. Hygiene. 90, 195\u2013210 (2014).","journal-title":"Am. Soc. Trop. Med. Hygiene"},{"key":"61174_CR5","doi-asserted-by":"publisher","unstructured":"Ostler, M. W., Porter, J. H. & Buxton, O. M. Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies. JoVE 83, 50973 https:\/\/doi.org\/10.3791\/50973 (2014).","DOI":"10.3791\/50973"},{"key":"61174_CR6","doi-asserted-by":"publisher","first-page":"113102","DOI":"10.1016\/j.jpba.2020.113102","volume":"182","author":"V Londhe","year":"2020","unstructured":"Londhe, V. & Rajadhyaksha, M. Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS. J. Pharm. Biomed. Anal. 182, 113102 (2020).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"61174_CR7","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/FTD.0000000000000864","volume":"43","author":"L Delahaye","year":"2021","unstructured":"Delahaye, L. et al. Alternative sampling devices to collect dried blood microsamples: state-of-the-art. Ther. Drug Monit. 43, 310\u2013321 (2021).","journal-title":"Ther. Drug Monit."},{"key":"61174_CR8","doi-asserted-by":"publisher","first-page":"8489","DOI":"10.1021\/ac5022562","volume":"86","author":"P Denniff","year":"2014","unstructured":"Denniff, P. & Spooner, N. Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal. Chem. 86, 8489\u20138495 (2014).","journal-title":"Anal. Chem."},{"key":"61174_CR9","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.4155\/bio.13.170","volume":"5","author":"R De Vries","year":"2013","unstructured":"De Vries, R. et al. The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium. Bioanalysis 5, 2147\u20132160 (2013).","journal-title":"Bioanalysis"},{"key":"61174_CR10","doi-asserted-by":"publisher","first-page":"158716","DOI":"10.1016\/j.scitotenv.2022.158716","volume":"854","author":"A Jain","year":"2023","unstructured":"Jain, A. et al. Hemoglobin normalization outperforms other methods for standardizing dried blood spot metabolomics: A comparative study. Sci. Total Environ. 854, 158716 (2023).","journal-title":"Sci. Total Environ."},{"key":"61174_CR11","doi-asserted-by":"publisher","first-page":"e0283149","DOI":"10.1371\/journal.pone.0283149","volume":"18","author":"G Michielin","year":"2023","unstructured":"Michielin, G. et al. Clinical sensitivity and specificity of a high-throughput microfluidic nano-immunoassay combined with capillary blood microsampling for the identification of anti-SARS-CoV-2 Spike IgG serostatus. PLoS ONE. 18, e0283149 (2023).","journal-title":"PLoS ONE"},{"key":"61174_CR12","doi-asserted-by":"publisher","first-page":"169383","DOI":"10.1016\/j.scitotenv.2023.169383","volume":"912","author":"LM Petrick","year":"2024","unstructured":"Petrick, L. M. et al. Effects of storage temperature and time on metabolite profiles measured in dried blood spots, dried blood microsamplers, and plasma. Sci. Total Environ. 912, 169383 (2024).","journal-title":"Sci. Total Environ."},{"key":"61174_CR13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1373\/clinchem.2017.275966","volume":"64","author":"JD Freeman","year":"2018","unstructured":"Freeman, J. D. et al. State of the science in dried blood spots. Clin. Chem. 64, 656\u2013679 (2018).","journal-title":"Clin. Chem."},{"key":"61174_CR14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4155\/bio.11.68","volume":"3","author":"JE Burnett","year":"2011","unstructured":"Burnett, J. E. Dried blood spot sampling: practical considerations and recommendation for use with preclinical studies. Bioanalysis 3, 1099\u20131107 (2011).","journal-title":"Bioanalysis"},{"key":"61174_CR15","doi-asserted-by":"publisher","first-page":"1631S","DOI":"10.1093\/jn\/131.5.1631S","volume":"131","author":"JV Mei","year":"2001","unstructured":"Mei, J. V., Alexander, J. R., Adam, B. W. & Hannon, W. H. Use of filter paper for the collection and analysis of human whole blood specimens. J. Nutr. 131, 1631S\u20131636S (2001).","journal-title":"J. Nutr."},{"key":"61174_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/14760584.2022.2013821","volume":"21","author":"TA Holroyd","year":"2022","unstructured":"Holroyd, T. A. et al. Diagnostic accuracy of dried blood spots for serology of vaccine-preventable diseases: a systematic review. Expert Rev. Vaccines. 21, 185\u2013200 (2022).","journal-title":"Expert Rev. Vaccines"},{"key":"61174_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1128\/CVI.05537-11","volume":"19","author":"GP Smits","year":"2012","unstructured":"Smits, G. P., Van Gageldonk, P. G., Schouls, L. M., Van Der Klis, F. R. M. & Berbers, G. A. M. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus. Clin. Vaccine Immunol. 19, 396\u2013400 (2012).","journal-title":"Clin. Vaccine Immunol."},{"key":"61174_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","volume":"335","author":"PGM Van Gageldonk","year":"2008","unstructured":"Van Gageldonk, P. G. M., Van Schaijk, F. G., Van Der Klis, F. R. & Berbers, G. A. M. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus. J. Immunol. Methods. 335, 79\u201389 (2008).","journal-title":"J. Immunol. Methods"},{"key":"61174_CR19","doi-asserted-by":"publisher","first-page":"127425","DOI":"10.1016\/j.vaccine.2025.127425","volume":"61","author":"CN Mburu","year":"2025","unstructured":"Mburu, C. N. et al. Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009\u20132021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016. Vaccine 61, 127425 (2025).","journal-title":"Vaccine"},{"key":"61174_CR20","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1128\/CVI.00144-07","volume":"14","author":"RF Helfand","year":"2007","unstructured":"Helfand, R. F. et al. Dried blood spots versus sera for detection of rubella virus-specific immunoglobulin M (IgM) and IgG in samples collected during a rubella outbreak in peru. Clin. Vaccine Immunol. 14, 1522\u20131525 (2007).","journal-title":"Clin. Vaccine Immunol."},{"issue":"Suppl 1","key":"61174_CR21","doi-asserted-by":"publisher","first-page":"S564","DOI":"10.1093\/infdis\/jir088","volume":"204","author":"A Uzicanin","year":"2011","unstructured":"Uzicanin, A. et al. Dried blood spots on filter paper as an alternative specimen for measles diagnostics: detection of measles immunoglobulin M antibody by a commercial enzyme immunoassay. J. Infect. Dis. 204 (Suppl 1), S564\u2013569 (2011).","journal-title":"J. Infect. Dis."},{"key":"61174_CR22","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/jmv.24136","volume":"87","author":"KE Colson","year":"2015","unstructured":"Colson, K. E. et al. Use of a commercial ELISA for the detection of measles-specific immunoglobulin G (IgG) in dried blood spots collected from children living in low-resource settings. J. Med. Virol. 87, 1491\u20131499 (2015).","journal-title":"J. Med. Virol."},{"key":"61174_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0166-0934(94)90052-3","volume":"49","author":"F Condorelli","year":"1994","unstructured":"Condorelli, F. et al. Detection of immunoglobulin G to measles virus, rubella virus, and mumps virus in serum samples and in microquantities of whole blood dried on filter paper. J. Virol. Methods. 49, 25\u201336 (1994).","journal-title":"J. Virol. Methods"},{"key":"61174_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/0004563220981106","volume":"58","author":"SJ Moat","year":"2021","unstructured":"Moat, S. J. et al. Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens. Ann. Clin. Biochem. 58, 123\u2013131 (2021).","journal-title":"Ann. Clin. Biochem."},{"key":"61174_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10989-023-10570-x","volume":"29","author":"S Kaareddy","year":"2023","unstructured":"Kaareddy, S. et al. Dried blood spot sampling in protein and peptide bioanalysis: optimism, experience, and the path forward. Int. J. Pept. Res. Ther. 29, 97 (2023).","journal-title":"Int. J. Pept. Res. Ther."},{"key":"61174_CR26","doi-asserted-by":"publisher","first-page":"815","DOI":"10.4155\/bio-2018-0010","volume":"10","author":"K Bloem","year":"2018","unstructured":"Bloem, K. et al. Capillary blood microsampling to determine serum biopharmaceutical concentration: Mitra \u00ae microsampler vs dried blood spot. Bioanalysis 10, 815\u2013823 (2018).","journal-title":"Bioanalysis"},{"key":"61174_CR27","first-page":"701","volume":"81","author":"MA Riddell","year":"2003","unstructured":"Riddell, M. A., Byrnes, G. B., Leydon, J. A. & Kelly, H. A. Dried venous blood samples for the detection and quantification of measles IgG using a commercial enzyme immunoassay. Bull. World Health Organ. 81, 701\u2013707 (2003).","journal-title":"Bull. World Health Organ."},{"key":"61174_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/diagnostics13030349","volume":"13","author":"M Rodr\u00edguez-Mateos","year":"2023","unstructured":"Rodr\u00edguez-Mateos, M. et al. Effect of the hematocrit and storage temperature of dried blood samples in the serological study of mumps, measles and rubella. Diagnostics 13, 349 (2023).","journal-title":"Diagnostics"},{"key":"61174_CR29","doi-asserted-by":"crossref","unstructured":"Carpenter, J. F., Manning, M. C. & Randolph, T. W. Long-term storage of proteins. CP Protein Sci. 27, 4\u20136 (2002).","DOI":"10.1002\/0471140864.ps0406s27"},{"key":"61174_CR30","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1074\/mcp.RA117.000015","volume":"16","author":"J Bj\u00f6rkesten","year":"2017","unstructured":"Bj\u00f6rkesten, J. et al. Stability of proteins in dried blood spot biobanks. Mol. Cell. Proteom. 16, 1286\u20131296 (2017).","journal-title":"Mol. Cell. Proteom."},{"key":"61174_CR31","doi-asserted-by":"publisher","first-page":"20549","DOI":"10.1038\/s41598-021-99911-8","volume":"11","author":"K Whittaker","year":"2021","unstructured":"Whittaker, K. et al. Dried blood sample analysis by antibody array across the total testing process. Sci. Rep. 11, 20549 (2021).","journal-title":"Sci. Rep."},{"key":"61174_CR32","doi-asserted-by":"publisher","first-page":"a029454","DOI":"10.1101\/cshperspect.a029454","volume":"9","author":"N Burdin","year":"2017","unstructured":"Burdin, N., Handy, L. K. & Plotkin, S. A. What Is wrong with pertussis vaccine immunity? The problem of waning effectiveness of pertussis vaccines. Cold Spring Harb Perspect. Biol. 9, a029454 (2017).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"61174_CR33","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","volume":"24","author":"AM Wendelboe","year":"2005","unstructured":"Wendelboe, A. M., Van Rie, A., Salmaso, S. & Englund, J. A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Disease J. 24, S58\u2013S61 (2005).","journal-title":"Pediatr. Infect. Disease J."},{"key":"61174_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.12688\/gatesopenres.15569.2","volume":"8","author":"EW Kagucia","year":"2025","unstructured":"Kagucia, E. W. et al. Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration. Gates Open. Res. 8, 60 (2025).","journal-title":"Gates Open. Res."},{"key":"61174_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/ije\/dys062","volume":"41","author":"JAG Scott","year":"2012","unstructured":"Scott, J. A. G. et al. Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int. J. Epidemiol. 41, 650\u2013657 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"61174_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/ije\/dyu251","volume":"44","author":"D Beguy","year":"2015","unstructured":"Beguy, D. et al. Health & demographic surveillance system profile: the nairobi urban health and demographic surveillance system (NUHDSS). Int. J. Epidemiol. 44, 462\u2013471 (2015).","journal-title":"Int. J. Epidemiol."},{"key":"61174_CR37","doi-asserted-by":"publisher","first-page":"S274","DOI":"10.1093\/cid\/ciz609","volume":"69","author":"SA Cunningham","year":"2019","unstructured":"Cunningham, S. A. et al. Health and demographic surveillance systems within the child health and mortality prevention surveillance network. Clin. Infect. Dis. 69, S274\u2013S279 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"61174_CR38","doi-asserted-by":"publisher","first-page":"e0000883","DOI":"10.1371\/journal.pgph.0000883","volume":"2","author":"AO Etyang","year":"2022","unstructured":"Etyang, A. O. et al. SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021. PLOS Glob Public. Health. 2, e0000883 (2022).","journal-title":"PLOS Glob Public. Health"},{"key":"61174_CR39","doi-asserted-by":"publisher","first-page":"e13173","DOI":"10.1111\/irv.13173","volume":"17","author":"EW Kagucia","year":"2023","unstructured":"Kagucia, E. W. et al. SARS-CoV\u20102 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February\u2013December 2022. Influenza Resp. Viruses. 17, e13173 (2023).","journal-title":"Influenza Resp. Viruses"},{"key":"61174_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ijid.2020.02.047","volume":"94","author":"RA Vos","year":"2020","unstructured":"Vos, R. A. et al. High varicella zoster virus susceptibility in Caribbean island populations: Implications for vaccination. Int. J. Infect. Dis. 94, 16\u201324 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"61174_CR41","doi-asserted-by":"publisher","unstructured":"Mburu, C. et al. Seroprevalence of antibodies against Diphtheria, Tetanus and Pertussis over a 12-year period in children in Kilifi, Kenya (2009\u20132021). Preprint at (2025). https:\/\/doi.org\/10.1101\/2025.10.07.25337523","DOI":"10.1101\/2025.10.07.25337523"},{"key":"61174_CR42","unstructured":"R Core Team. R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61174-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:55:51Z","timestamp":1791244551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61174-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61174-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9214370\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Study participants aged\u2009\u2265\u200918 years provided written informed consent, while for those\u2009<\u200918 years, written consent was obtained from parents\/guardians, with written assent for children aged 13\u201317 years. Ethical approval was obtained from the Kenya Medical Research Institute Scientific and Ethics Review Unit (KEMRI\/SERU\/CGMR-C\/203\/4085).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"31046"}}